Lake Street Capital Issues Positive Forecast for LENSAR (NASDAQ:LNSR) Stock Price

LENSAR (NASDAQ:LNSR) had its price target upped by Lake Street Capital from $12.00 to $16.00 in a research note published on Friday,Benzinga reports. They currently have a buy rating on the stock.

LENSAR Stock Up 19.6 %

LNSR opened at $13.00 on Friday. LENSAR has a 52-week low of $2.67 and a 52-week high of $13.18. The company has a 50 day moving average of $9.58 and a two-hundred day moving average of $7.05. The company has a market cap of $151.00 million, a P/E ratio of -8.90 and a beta of 0.66.

LENSAR (NASDAQ:LNSR) last posted its earnings results on Thursday, February 27th. The company reported ($1.61) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($1.40). LENSAR had a negative return on equity of 49.02% and a negative net margin of 34.03%. The firm had revenue of $16.73 million for the quarter, compared to analyst estimates of $14.95 million.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Renaissance Technologies LLC lifted its position in shares of LENSAR by 13.3% during the fourth quarter. Renaissance Technologies LLC now owns 348,891 shares of the company’s stock worth $3,119,000 after purchasing an additional 40,946 shares in the last quarter. Geode Capital Management LLC raised its holdings in LENSAR by 5.6% in the fourth quarter. Geode Capital Management LLC now owns 106,058 shares of the company’s stock valued at $948,000 after acquiring an additional 5,627 shares in the last quarter. Brandes Investment Partners LP raised its holdings in LENSAR by 10.4% in the fourth quarter. Brandes Investment Partners LP now owns 489,318 shares of the company’s stock valued at $4,375,000 after acquiring an additional 45,920 shares in the last quarter. Essex Investment Management Co. LLC raised its holdings in LENSAR by 18.3% in the fourth quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company’s stock valued at $357,000 after acquiring an additional 6,184 shares in the last quarter. Finally, Atria Investments Inc raised its holdings in LENSAR by 28.2% in the fourth quarter. Atria Investments Inc now owns 26,055 shares of the company’s stock valued at $233,000 after acquiring an additional 5,729 shares in the last quarter. 40.15% of the stock is owned by institutional investors and hedge funds.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.